Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$179.38

1.72 (0.97%)

07:35
07/10/18
07/10
07:35
07/10/18
07:35

Jazz Pharmaceuticals price target raised to $205 from $162 at Citi

Citi analyst Liav Abraham raised her price target for Jazz Pharmaceuticals to $205 and keeps a Buy rating on the shares. The analyst remains a constructive stance on Jazz given the potential for upside to consensus estimates. Further, balance sheet optionality can support business development and drive revenue diversification, Abraham tells investors in a research note. The analyst also has increased confidence in the commercial opportunity for solriamfetol.

  • 27

    Oct

  • 20

    Dec

JAZZ Jazz Pharmaceuticals
$179.38

1.72 (0.97%)

06/06/18
JPMS
06/06/18
NO CHANGE
Target $185
JPMS
Overweight
Jazz shares have 'substantial' appreciation potential, says JPMorgan
After attending the SLEEP conference where Jazz Pharmaceuticals presented a number of clinical updates, JPMorgan analyst Jessica Fye says JZP-110 "continues to impress." The analyst came away comfortable with her $450M peak forecast for the product. She expects approval in December and launch in Q1 of 2019. Fye continues to see potential for "substantial further stock appreciation" for Jazz over time and keeps an Overweight rating on the shares with a $185 price target.
06/06/18
RHCO
06/06/18
NO CHANGE
Target $210
RHCO
Buy
Physicians interested in Jazz's solriamfetol, Xyrem at SLEEP, says SunTrust
After attending the SLEEP conference where Jazz Pharmaceuticals presented data for its Sleep assets and provided an overview of the solriamfetol TONES 5 long-term data and Xyrem pediatric data, SunTrust analyst John Boris said interest from the scientific community in solriamfetol and Xyrem was "high," and that Jazz shared a range of data for solriamfetol, which derisks the asset from a regulatory standpoint ahead of the PDUFA date of December 20. Boris maintained his in-line 2022-end solriamfetol sales at $330M, with broad formulary acceptance unlikely until 2022 and reiterated a Buy rating on the shares with a $210 price target.
06/06/18
BMOC
06/06/18
NO CHANGE
Target $201
BMOC
Outperform
Jazz Pharmaceuticals 'looking strong in sleep,' says BMO Capital
After attending the SLEEP conference where Jazz Pharmaceuticals presented a number of clinical updates, BMO Capital analyst Gary Nachman said Jazz demonstrated that its sleep pipeline is progressing well and robust, telling investors in a research note that he continues to believe solriamfetol remains underappreciated. Additionally, Nachman contends that the Xyrem franchise could possibly be bolstered with a pediatric indication, and there could be further upside down the road from JZP-258 and a once-nightly low-sodium form of oxybate. Nachman keeps an Outperfom rating on the shares with a $201 price target.
07/02/18
WELS
07/02/18
NO CHANGE
WELS
Outperform
Wells sees 'strong rationale' in Jazz sale of Prialt rights
Wells Fargo analyst David Maris sees "strong rationale" in Jazz Pharmaceuticals' agreement to sell its rights related to Prialt to TerSera Therapeutics for $80M in cash, or 2.96 times sales. The deal should allow Jazz to focus more on the therapeutic areas it has repeatedly stated are core to its current and future business: sleep medicine and hematology/oncology, Maris tells investors in a research note. He believes business development will remain a key focus for Jazz and keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

S

Sprint

$6.35

-0.04 (-0.63%)

11:20
10/15/18
10/15
11:20
10/15/18
11:20
Options
Size ratio spread in Sprint »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

11:20
10/15/18
10/15
11:20
10/15/18
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$14.29

-0.08 (-0.56%)

11:17
10/15/18
10/15
11:17
10/15/18
11:17
Technical Analysis
Technical Take: Huntington Bancshares breaks support »

The shares are down 0.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

PAR

PAR Technology

$20.31

-0.69 (-3.29%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Hot Stocks
Voss Capital supports ADW's call for PAR Technology board to pursue alternatives »

Voss Capital, LLC, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/15/18
10/15
11:16
10/15/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$59.01

-0.67 (-1.12%)

11:15
10/15/18
10/15
11:15
10/15/18
11:15
Options
Weibo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
10/15/18
10/15
11:15
10/15/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:13
10/15/18
10/15
11:13
10/15/18
11:13
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

11:10
10/15/18
10/15
11:10
10/15/18
11:10
General news
Treasury announced a $25 B 8-week bill for the inaugural sale Tuesday »

Treasury announced a $25…

TXT

Textron

$65.88

0.81 (1.24%)

11:06
10/15/18
10/15
11:06
10/15/18
11:06
Hot Stocks
TRU Simulation + Training, FlightSafety International enter LOI to form JV »

TRU Simulation +…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

11:05
10/15/18
10/15
11:05
10/15/18
11:05
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

11:05
10/15/18
10/15
11:05
10/15/18
11:05
General news
Today's U.S. reports »

Today's U.S. reports…

MANU

Manchester United

$21.87

0.59 (2.77%)

11:03
10/15/18
10/15
11:03
10/15/18
11:03
Periodicals
Manchester United target for possible takeover by Saudi prince, The Sun says »

Saudi Crown Prince…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$75.53

-1.43 (-1.86%)

, EQIX

Equinix

$399.68

3.96 (1.00%)

11:03
10/15/18
10/15
11:03
10/15/18
11:03
Hot Stocks
NetApp appoints Debra McCowan as chief human resources officer »

NetApp (NTAP) announced…

NTAP

NetApp

$75.53

-1.43 (-1.86%)

EQIX

Equinix

$399.68

3.96 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 10

    Dec

SMH

Market Vectors Semiconductor

$96.42

-0.92 (-0.95%)

11:03
10/15/18
10/15
11:03
10/15/18
11:03
Technical Analysis
Technical Take: Market Vectors Semiconductor breaks support, nears 52-week lows »

The Market Vectors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMB

iShares JP Morgan USD Emerging Markets Bond ETF

$105.88

0.04 (0.04%)

11:00
10/15/18
10/15
11:00
10/15/18
11:00
Options
Position adjustment in Emerging Markets bond ETF »

Position adjustment in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$5.25

0.11 (2.14%)

10:58
10/15/18
10/15
10:58
10/15/18
10:58
Hot Stocks
Viceroy: MiMedx's appointment of Alvarez, Marsal 'conflict of interest' »

In an open letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ATVI

Activision Blizzard

$74.92

-3.07 (-3.94%)

, MCD

McDonald's

$164.56

0.74 (0.45%)

10:57
10/15/18
10/15
10:57
10/15/18
10:57
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

ATVI

Activision Blizzard

$74.92

-3.07 (-3.94%)

MCD

McDonald's

$164.56

0.74 (0.45%)

TPR

Tapestry

$42.89

-0.92 (-2.10%)

LULU

Lululemon

$143.24

-0.46 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 19

    Nov

10:55
10/15/18
10/15
10:55
10/15/18
10:55
Conference/Events
Wedbush restaurants analyst to hold a luncheon »

Restaurants Analyst…

WPC

W.P. Carey

$63.80

0.61 (0.97%)

, GPN

Global Payments

$115.68

-1.72 (-1.47%)

10:54
10/15/18
10/15
10:54
10/15/18
10:54
Conference/Events
Wedbush IT services & payments analyst to hold dinner meeting »

In conjunction with the…

WPC

W.P. Carey

$63.80

0.61 (0.97%)

GPN

Global Payments

$115.68

-1.72 (-1.47%)

FDC

First Data

$23.21

0.02 (0.09%)

TSS

TSYS

$92.71

-1.235 (-1.31%)

SQ

Square

$73.51

-0.455 (-0.62%)

PYPL

PayPal

$77.74

-1.28 (-1.62%)

MA

MasterCard

$200.90

-3.06 (-1.50%)

V

Visa

$138.45

-1.57 (-1.12%)

ADS

Alliance Data

$211.66

-2.09 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 21

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 26

    Nov

  • 03

    Mar

UNFI

United Natural Foods

$26.66

-0.48 (-1.77%)

, SVU

Supervalu

$32.47

-0.005 (-0.02%)

10:54
10/15/18
10/15
10:54
10/15/18
10:54
Recommendations
United Natural Foods, Supervalu analyst commentary  »

RBC says United Natural…

UNFI

United Natural Foods

$26.66

-0.48 (-1.77%)

SVU

Supervalu

$32.47

-0.005 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

NUGT

Direxion Gold Miners Bull

$16.72

1.32 (8.57%)

10:51
10/15/18
10/15
10:51
10/15/18
10:51
Technical Analysis
Technical Take: Direxion Gold Miners Bull has bullish price pattern »

There is an active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CL

Colgate-Palmolive

$62.80

0.26 (0.42%)

10:50
10/15/18
10/15
10:50
10/15/18
10:50
Options
Put sales in Colgate as implied volatility reaches 52-week highs »

Put sales in Colgate as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.